Search - tctmd.com

Displaying 981 - 1000 of 2333

Sort: Relevancy | Date

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

July 02, 2018

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

News Daily News

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

June 25, 2018

Intraprocedural Efficiencies

Presentation The Structural Heart Disease Summit 2018

Intraprocedural Efficiencies

Presenter: Janet F. Wyman

June 21, 2018

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

News Daily News

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Yael L. Maxwell

June 14, 2018

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

News Daily News

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

June 11, 2018

Medical Device R&D Dropped by $34 Million Following Introduction of Controversial Excise Tax

News Daily News

Medical Device R&D Dropped by $34 Million Following Introduction of Controversial Excise Tax

Yael L. Maxwell

June 11, 2018

Advent of High-Sensitivity Troponin Tests in Sweden Leads to Only Small Uptick in MI Diagnoses

News Daily News

Advent of High-Sensitivity Troponin Tests in Sweden Leads to Only Small Uptick in MI Diagnoses

June 06, 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

May 25, 2018

News Industry News

PiCSO therapy reduces infarct size in STEMI patients. Miracor Medical announces new publication at EuroPCR

May 24, 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

May 22, 2018

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

News Daily News

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

May 16, 2018

CT Imaging in Ischemic Heart Disease: CTA, CT-FFR, and CT-Perfusion Current Uses and Future Projections

Presentation Intravascular Coronary Imaging and Physiology 2018

CT Imaging in Ischemic Heart Disease: CTA, CT-FFR, and CT-Perfusion Current Uses and Future Projections

Presenter: Jane Cao

May 06, 2018

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

News Daily News

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

May 04, 2018

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

News Industry News

Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy

May 01, 2018

Number of Cigarettes Smoked per Day Influences Stroke Risk in Young Men

News Daily News

Number of Cigarettes Smoked per Day Influences Stroke Risk in Young Men

April 19, 2018

Heart Transplants From Overdose Deaths Are Soaring, With Promising Results

News Daily News

Heart Transplants From Overdose Deaths Are Soaring, With Promising Results

Yael L. Maxwell

April 17, 2018

Abciximab in ‘Short Supply’ Worldwide

News Daily News

Abciximab in ‘Short Supply’ Worldwide

April 13, 2018

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

News Daily News

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

April 03, 2018

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

News Daily News

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Yael L. Maxwell

March 30, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.